Cancel
Rekha Sathyanarayana
Senior Vice President, Clinical Operations
@
Stealth BioTherapeutics
djwf8.z6zv66xi53u8q8@fz864gwg5.f6z
Sign up to see email
Known information
- Has more than 25 years of diverse therapeutic experience in pharmaceutical development.
- Has over 15 years of experience in key leadership positions as Head of Clinical Operations.
- Has overseen global pivotal trials at Pharma, CRO, and Biotech that culminated in bringing 6 commercial products to market.
- Was Vice President of Clinical Operations at Titan Pharmaceuticals, leading programs in Parkinson’s Disease and Opioid addiction, including receiving a NIDA grant.
- Led her department through IND and BLA enabling programs at Revance Therapeutics.
- Led a cancer vaccine program at Bavarian Nordic A/S.
- Was pivotal in securing NDA approvals of 3 commercial products at Depomed Inc.
- Held increasing responsibilities at Neopath Inc, R2 Technologies, PPD Inc, and Abbott Labs that yielded 510K and NDA approvals.
- Holds a BS in Microbiology from Bangalore University.
- Holds an advanced BS in Medical Technology from Northern Illinois University.
- Has attained Executive Leadership Management certification from Stanford University Graduate School of Business.
About Stealth BioTherapeutics
Stealth BioTherapeutics develops therapies for mitochondrial dysfunction related to genetic diseases and aging, with a focus on elamipretide and SBT-272 in clinical studies.
Report inaccurate information
